1.
Haas ME, Aragam KG, Emdin CA, et al. Genetic Association of Albuminuria with Cardiometabolic Disease and Blood Pressure. Am J Hum Genet. 2018;103(4):461-473. doi:10.1016/j.ajhg.2018.08.004.
1.
Warren CR, O’Sullivan JF, Friesen M, et al. Induced Pluripotent Stem Cell Differentiation Enables Functional Validation of GWAS Variants in Metabolic Disease. Cell Stem Cell. 2017;20(4):547-557.e7. doi:10.1016/j.stem.2017.01.010.
1.
Hotamışlıgil GS. Endoplasmic reticulum stress and the inflammatory basis of metabolic disease. Cell. 2010;140(6):900-17. doi:10.1016/j.cell.2010.02.034.
1.
Roberts LD, Boström P, O’Sullivan JF, et al. β-Aminoisobutyric acid induces browning of white fat and hepatic β-oxidation and is inversely correlated with cardiometabolic risk factors. Cell Metab. 2014;19(1):96-108. doi:10.1016/j.cmet.2013.12.003.
1.
Delahanty LM, Pan Q, Jablonski KA, et al. Effects of weight loss, weight cycling, and weight loss maintenance on diabetes incidence and change in cardiometabolic traits in the Diabetes Prevention Program. Diabetes Care. 2014;37(10):2738-45. doi:10.2337/dc14-0018.
1.
Efeyan A, Comb WC, Sabatini DM. Nutrient-sensing mechanisms and pathways. Nature. 2015;517(7534):302-10. doi:10.1038/nature14190.
1.
Croteau-Chonka DC, Rogers AJ, Raj T, et al. Expression Quantitative Trait Loci Information Improves Predictive Modeling of Disease Relevance of Non-Coding Genetic Variation. PLoS One. 2015;10(10):e0140758. doi:10.1371/journal.pone.0140758.